| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.31B | 30.45B | 29.29B | 24.84B | 27.45B | 34.24B |
| Gross Profit | 16.45B | 14.87B | 14.27B | 11.81B | 16.04B | 16.04B |
| EBITDA | 10.64B | 10.50B | 8.58B | 6.79B | 11.71B | 12.71B |
| Net Income | 6.34B | 5.86B | 5.01B | 3.75B | 7.03B | 7.60B |
Balance Sheet | ||||||
| Total Assets | 228.02B | 323.03B | 222.69B | 203.81B | 189.24B | 200.47B |
| Cash, Cash Equivalents and Short-Term Investments | 70.99B | 58.42B | 77.64B | 78.20B | 74.71B | 82.71B |
| Total Debt | 81.10B | 168.53B | 76.13B | 47.66B | 46.85B | 43.35B |
| Total Liabilities | 93.58B | 187.05B | 88.92B | 72.39B | 58.80B | 73.32B |
| Stockholders Equity | 134.44B | 135.98B | 133.77B | 131.41B | 130.44B | 127.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -108.14B | -8.77B | 4.89B | -4.21B | 18.24B |
| Operating Cash Flow | 0.00 | -5.02B | -8.46B | 5.09B | -4.11B | 18.35B |
| Investing Cash Flow | 0.00 | -102.94B | -15.37B | -179.00M | 2.13B | -2.33B |
| Financing Cash Flow | 0.00 | 88.75B | 23.27B | -1.43B | -3.79B | -4.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥36.97B | 5.76 | ― | 3.01% | 7.25% | 36.43% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥41.89B | 7.74 | ― | 6.02% | -5.07% | -26.79% | |
62 Neutral | ¥2.81T | 7.65 | 11.39% | 2.93% | 2.61% | 10.15% | |
59 Neutral | ¥6.16B | 12.20 | 2.90% | 4.53% | -12.48% | -34.07% | |
58 Neutral | ¥121.77B | 20.27 | 4.48% | 3.30% | 3.93% | 16.91% | |
56 Neutral | ¥55.08B | 11.83 | 6.98% | 7.35% | 9.08% | -42.76% |